BENITEC LTD
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. Their transformational technology, ddRNAi, targets and ‘turns off’ specific genes related to disease, providing lasting treatment and potentially cure with a single dose. Compared to traditional approaches to RNA intereference, ddRNAi is easier to deliver, safer to us, more targeted and more efficient. Benitec has a pipeline of in-house and partnered dru... g development programs based on ddRNAI, including Hepatitis C and B, cancer-associated pain and drug-resistant lung cancer. Our Hepatitis C program is nearing clinical trials in 2013. ddRNAi has the potential to silence genes related to thousands of human diseases and is protected by over 40 global patents. The technology is available from Benitec under a variety of licence options.
BENITEC LTD
Industry:
Biotechnology Genetics Health Diagnostics Medical Therapeutics
Founded:
2001-01-01
Address:
Hayward, California, United States
Country:
United States
Website Url:
http://www.benitec.com
Total Employee:
11+
Status:
Active
Contact:
4089602207
Total Funding:
118.99 M USD
Technology used in webpage:
Apache PostalAddress Schema Gravity Forms Amazon Frankfurt Region Corporation Schema QuoteMedia
Similar Organizations
Applied StemCell
Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.
Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Dr Lal PathLabs
Late Dr. (Major) S.K. Lal, a pioneer in the field of pathology who had been trained in the army and later at the Cook County Hospital,
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Natera
Natera specializes in cell-free DNA testing to elevate the science and utility of prenatal testing.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Vilya
Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Mr Peter Francis Non-Executive Director @ Benitec Ltd
Non-Executive Director
Greg West CEO @ Benitec Ltd
CEO
2016-08-01
Dr Jerel A Banks Executive Chairman and CEO @ Benitec Ltd
Executive Chairman and CEO
2016-10-25
Michael Graham Scientific Consultant @ Benitec Ltd
Scientific Consultant
Cliff Holloway COO @ Benitec Ltd
COO
2016-08-01
Melvyn Bridges Director @ Benitec Ltd
Director
2006-02-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-10-11 | Tacere Therapeutics | Tacere Therapeutics acquired by Benitec Ltd | N/A |
Investors List
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Benitec Ltd
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Benitec Ltd
Nantahala Capital Management
Nantahala Capital Management investment in Post-IPO Equity - Benitec Ltd
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Benitec Ltd
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - Benitec Ltd
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Benitec Ltd
NantCapital
NantCapital investment in Post-IPO Equity - Benitec Ltd
Official Site Inspections
http://www.benitec.com
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Benitec Ltd"
Company Info :: Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The proprietary platform, …See details»
For Investors :: Benitec Biopharma Inc. (BNTC)
Feb 14, 2025 Benitec Biopharma Inc. 3940 Trust Way Hayward, CA 94545 T: +1 (510) 780-0634 Investor Relations. LifeSci Advisors Irina Koffler Managing Director T: 646-970-4681 ikoffler@lifesciadvisors.com. Transfer Agent. …See details»
Benitec Ltd - Crunchbase Company Profile & Funding
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and life-threatening human diseases. Their transformational technology, ddRNAi, targets and …See details»
Benitec Biopharma Inc. - LinkedIn
Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long …See details»
Benitec Biopharma - Wikipedia
Benitec Biopharma Limited is an Australian biotechnology company founded in 1997. [1] It is engaged in the development of gene-silencing therapies for the treatment of chronic and life …See details»
Benitec Biopharma Inc. Announces Pricing of $30 Million Common …
13 hours ago HAYWARD, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, …See details»
Benitec Biopharma - Overview, News & Similar companies
May 14, 2024 Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma …See details»
Benitec Biopharma
5 days ago Benitec Biopharma. We value your privacy. We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking …See details»
Benitec Biopharma Company Profile - Office Locations ... - Craft
Oct 28, 2024 Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy. It aims to provide the silencing of disease …See details»
BENITEC BIOPHARMA INC.
BENITEC BIOPHARMA INC. (Exact name of registrant as specified in its charter) Delaware 84-462-0206 (State or other jurisdiction of incorporation or organization) (IRS Employer …See details»
Benitec Biopharma Inc. Announces Pricing of $30 ... - Markets Insider
13 hours ago Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with …See details»
Benitec Biopharma Announces Appointment of Kishen Mehta to …
HAYWARD, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology …See details»
Benitec Ltd - Funding, Financials, Valuation & Investors - Crunchbase
Benitec Ltd is registered under the ticker NASDAQ:BNTC . Benitec Ltd is funded by 5 investors. Adage Capital Management and Suvretta Capital Management are the most recent investors. …See details»
S-8: Initial registration statement for securities to be offered to ...
Benitec Biopharma Inc. (Exact name of registrant as specified in its charter) Delaware 3940 Trust Way. Hayward, California 94545 (510) 780-0819 84-462-0206 (State or other jurisdiction of. …See details»
Benitec Biopharma prices $30M securities offerings
12 hours ago Benitec Biopharma (BNTC) aims to raise $30M through stock and pre-funded warrant offerings. Proceeds to fund product development and corporate growth.See details»
Benitec Biopharma Inc. Announces Pricing of $30 Million
13 hours ago Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with …See details»
Benitec Biopharma Releases First Quarter 2025 Financial Results …
Nov 14, 2024 Benitec Biopharma Inc.-Positive 270-day Interim Clinical Study Data for the First Subject and Positive 180-day Interim Clinical Study Data for the Second Subject Treated with …See details»
Benitec Biopharma Reports Positive Interim Results For BB-301
6 days ago Benitec's CEO, Dr. Jerel A. Banks, expressed gratitude to the participants and their families, emphasizing optimism for continued benefits as the trial progresses. The sixth and …See details»
Benitec Biopharma to Participate in Upcoming Conferences in
Feb 26, 2025 Benitec Biopharma Inc. (“Benitec” or the “Company”) is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with …See details»
Benitec Biopharma Inc.
Benitec Biopharma Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 08205P100 (CUSIP Number) August 8, 2023 (Date of Event which Requires Filing …See details»